Text Messaging Tracks Use of Postop Opioid Prescriptions
Patients did not use about 60 percent of prescribed opioid tablets following common orthopedic or urologic procedures.
Pain Management
Minocycline May Reduce Pain of Some Patients With Neuropathic Pain
The researchers reviewed studies evaluating the effectiveness of minocycline in alleviating neuropathic pain because it reduces microglial activation, which suggests that it may reduce neuropathic pain.
Increase Seen in Co-Involvement of Opioids in Drug Overdose Deaths
There have been recent increases in overdose deaths involving both cocaine and opioids and involving both psychostimulants and opioids.
Atogepant Under Review for Episodic Migraine Prevention
Atogepant is an investigational orally administered calcitonin gene-related peptide (CGRP) receptor antagonist.
Drug Combo Superior to Placebo for Posttraumatic Headache
For patients with acute posttraumatic headache presenting to the emergency department, intravenous M+D is more efficacious than placebo.
Trans-Nasal High-Flow Dehumidified Air May Reduce Acute Migraine Headache Pain
Researchers compared the impact of dry oxygen, dry air, humidified oxygen, and humidified air on patients suffering from acute headache episodes.
Psychological Considerations for Patients With Painful Diabetic Neuropathy
This article discusses how to assess patients with neuropathic pain in relation to psychological aspects of their health and cognitive behavioral interventions to improve their quality of life.
Oral Celecoxib Solution May Provide Short-Term Pain Relief for Migraine
Liquid solution celecoxib may offer headache relief and improvements in functional disability in patients with migraine.
ACTTION Partnership Publishes New Acute Neuropathic Pain Diagnostic Criteria
The collaborative group believes that diagnostic criteria for acute neuropathic pain should provide a framework for research on and treatment of these complex pain conditions.
Neuropathic Pain and COVID-19: Current Understanding and Future Directions
In this narrative review, the researchers examine the potential for neuropathic pain that develops weeks to months after COVID-19.
-
Loading...
-
Loading...
Next post in Neuropathy
